MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-   B9012 BRD 7389Summary: P90 RSK inhibitor B9012 BRD 7389Summary: P90 RSK inhibitor
-   B5640 HI TOPK 032Summary: T-LAK-cell-originated protein kinase (TOPK) inhibitor B5640 HI TOPK 032Summary: T-LAK-cell-originated protein kinase (TOPK) inhibitor
-   A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
-   A3288 CC-930Target: JNKSummary: JNK inhibitor,potent and selective A3288 CC-930Target: JNKSummary: JNK inhibitor,potent and selective
-   A3943 XMD8-92Target: ERKSummary: BMK1/ERK5 inhibitor A3943 XMD8-92Target: ERKSummary: BMK1/ERK5 inhibitor
-   A1663 PD980599 CitationTarget: MEKSummary: MEK inhibitor,selective and reversible A1663 PD980599 CitationTarget: MEKSummary: MEK inhibitor,selective and reversible
-   A8435 FurosemideTarget: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA receptors antagonist A8435 FurosemideTarget: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA receptors antagonist
-   A9502 OTS964 hydrochlorideSummary: TOPK inhibitor,potent and selective A9502 OTS964 hydrochlorideSummary: TOPK inhibitor,potent and selective
-   C5545 MK2 Inhibitor IVTarget: MK2Summary: highly selective, non-ATP competitive MK2 inhibitor C5545 MK2 Inhibitor IVTarget: MK2Summary: highly selective, non-ATP competitive MK2 inhibitor
-   B2190 H 89 2HCl3 CitationSummary: Potent PKA inhibitor B2190 H 89 2HCl3 CitationSummary: Potent PKA inhibitor
